Translocation of Analogues of the Antimicrobial Peptides Magainin and Buforin across Human Cell Membranes*

Cationic antimicrobial peptides play important roles in innate immunity. Compared with extensive studies on peptide-bacteria interactions, little is known about peptide-human cell interactions. Using human cervical carcinoma HeLa and fibroblastic TM12 cells, we investigated the cellular uptake of fluorescent analogues of the two representative antimicrobial peptides magainin 2 and buforin 2 in comparison with the representative Arg-rich cell-penetrating Tat-(47–57) peptide (YGRKKRRQRRR). The dose, time, temperature, and energy dependence of translocation suggested that the three peptides cross cell membranes through different mechanisms. The magainin peptide was internalized within a time scale of tens of minutes. The cooperative concentration dependence of uptake suggested that the peptide forms a pore as an intermediate similar to the observations in model membranes. Furthermore, the translocation was coupled with cytotoxicity, which was larger for tumor HeLa cells. In contrast, the buforin peptide translocated within 10 min by a temperature-independent, less concentration-dependent passive mechanism without showing any significant cytotoxicity at the highest concentration investigated (100 μm). The uptake of the Tat peptide was proportional to the peptide concentration, and the concentration dependence was lost upon ATP depletion. The peptide exhibited a moderate cytotoxicity at higher concentrations. The time course did not show saturation even after 120 min. The buforin peptide, covalently attached to the 28-kDa green fluorescent protein, also entered cells, suggesting a potency of the peptide as a vector for macromolecular delivery into cells. However, the mechanism appeared to be different from that of the parent peptide.

[1]  G. Drin,et al.  Translocation of protegrin I through phospholipid membranes: role of peptide folding. , 2002, Biochimica et biophysica acta.

[2]  S. Futaki,et al.  Possible Existence of Common Internalization Mechanisms among Arginine-rich Peptides* , 2002, The Journal of Biological Chemistry.

[3]  M. Zasloff Antimicrobial peptides of multicellular organisms , 2002, Nature.

[4]  K Sandvik,et al.  The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm , 2001, FEBS letters.

[5]  A. Mor,et al.  Affinity driven molecular transfer from erythrocyte membrane to target cells , 2001, Peptides.

[6]  R. Brasseur,et al.  Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. , 2001, Biochemistry.

[7]  K. Pattabiraman,et al.  The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Nordén,et al.  The Antennapedia peptide penetratin translocates across lipid bilayers – the first direct observation , 2000, FEBS letters.

[9]  D. Piwnica-Worms,et al.  Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.

[10]  H. Ginsburg,et al.  Antimalarial Activities of Dermaseptin S4 Derivatives , 2000, Antimicrobial Agents and Chemotherapy.

[11]  C. B. Park,et al.  Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. , 2000, Biochemistry.

[12]  K. Matsuzaki Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.

[13]  M. Itakura,et al.  Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. , 1999, European journal of biochemistry.

[14]  D. Dekkers,et al.  Lipid translocation across the plasma membrane of mammalian cells. , 1999, Biochimica et biophysica acta.

[15]  B. Wiesner,et al.  Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.

[16]  K. Matsuzaki,et al.  Magainins as paradigm for the mode of action of pore forming polypeptides. , 1998, Biochimica et biophysica acta.

[17]  R. Gallo,et al.  PR-39, a Syndecan-inducing Antimicrobial Peptide, Binds and Affects p130Cas * , 1998, The Journal of Biological Chemistry.

[18]  C. B. Park,et al.  Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.

[19]  R. Hancock,et al.  Cationic peptides: a new source of antibiotics. , 1998, Trends in biotechnology.

[20]  Y. Shai,et al.  Selective Cytotoxicity of Dermaseptin S3 toward IntraerythrocyticPlasmodium falciparum and the Underlying Molecular Basis* , 1997, The Journal of Biological Chemistry.

[21]  N. Fujii,et al.  Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. , 1997, Biochimica et biophysica acta.

[22]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[23]  N. Fujii,et al.  Modulation of magainin 2-lipid bilayer interactions by peptide charge. , 1997, Biochemistry.

[24]  N. Fujii,et al.  An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.

[25]  C. B. Park,et al.  A novel antimicrobial peptide from Bufo bufo gargarizans. , 1996, Biochemical and biophysical research communications.

[26]  B. Haimovich,et al.  Magainin-induced cytotoxicity in eukaryotic cells: kinetics, dose-response and channel characteristics. , 1995, Biochimica et biophysica acta.

[27]  K. Miyajima,et al.  Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. , 1995, Biochemistry.

[28]  N. Fujii,et al.  Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. , 1995, Biochemistry.

[29]  N. Fujii,et al.  Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. , 1995, Biochemistry.

[30]  M. Herlyn,et al.  Experimental local therapy of human melanoma with lytic magainin peptides , 1995, International journal of cancer.

[31]  N. Fujii,et al.  Orientational and aggregational states of magainin 2 in phospholipid bilayers. , 1994, Biochemistry.

[32]  M. Zasloff,et al.  Anticancer efficacy of Magainin2 and analogue peptides. , 1993, Cancer research.

[33]  A. Gazdar,et al.  Antitumor activity of magainin analogues against human lung cancer cell lines. , 1992, Cancer research.

[34]  J. Barker,et al.  Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Schmid,et al.  ATP is required for receptor-mediated endocytosis in intact cells , 1990, The Journal of cell biology.

[36]  H. Westerhoff,et al.  Interactions between a new class of eukaryotic antimicrobial agents and isolated rat liver mitochondria. , 1989, Biochimica et biophysica acta.

[37]  M. Zasloff,et al.  Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .

[38]  Robert E W Hancock,et al.  Role of membranes in the activities of antimicrobial cationic peptides. , 2002, FEMS microbiology letters.

[39]  A. Balows Development of novel antimicrobial agents: emerging strategies: Lohner, K. editor; 270pp, 2001, Horizon Scientific Press, Norfold, U.K. ISBN 1-8 98486-23-9 $135.00 , 2002 .

[40]  K. Lohner Development of novel antimicrobial agents: emerging strategies. , 2001 .

[41]  Alessandro Tossi,et al.  Amphipathic, α‐helical antimicrobial peptides , 2000 .